- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Durect Corp (DRRX)
| Open: | 0.7700 | Day's Range: | 0.7700 - 0.8499 | Volume: | 569,459 |
|---|---|---|---|---|---|
| Previous Close: | 0.8100 | 52wk Range: | 0.6101 - 1.8500 | 1-Yr Rtn: | +4.79% |
Key Statistics for DRRX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.1900 |
| Est. EPS (USD) (12/2013) | -0.2100 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 81.52 |
| Shares Outstanding (M) | 101.89 |
| 30 Day Average Volume | 869,644 |
| Price/Book (mrq) | 2.5528 |
| Price/Sale (ttm) | 4.3268 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DRRX
Company Profile & Key Executives for DRRX
Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.
| Felix TheeuwesChairman/Chief Scientific Ofcr | James E BrownPresident/CEO/Co-Founder |
| Matthew J HoganCFO/Secretary | Su Il YumExec VP:Pharmaceutical Sys |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DRRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page